Published in Arterioscler Thromb Vasc Biol on February 01, 2000
Lipoprotein(a): an elusive cardiovascular risk factor. Arterioscler Thromb Vasc Biol (2004) 1.48
Myocardial infarction in young adults. Postgrad Med J (2005) 1.32
Homocysteine, vitamin B12 and folate levels in premature coronary artery disease. BMC Cardiovasc Disord (2006) 1.02
Molecular targeting of proteins by L-homocysteine: mechanistic implications for vascular disease. Antioxid Redox Signal (2007) 1.01
Impaired nitric oxide-mediated flow-induced coronary dilation in hyperhomocysteinemia: morphological and functional evidence for increased peroxynitrite formation. Am J Pathol (2002) 0.93
Association between plasma homocysteine and microalbuminuria in persons without hypertension, diabetes mellitus, and cardiovascular disease. Clin Exp Nephrol (2010) 0.86
Lipoprotein(a), homocysteine, and retinal arteriosclerosis. Mol Vis (2008) 0.84
Folate and vitamin B12 status of a multiethnic adult population. J Natl Med Assoc (2006) 0.83
Plasma homocysteine and lipoprotein (a) levels in Turkish patients with metabolic syndrome. Heart Vessels (2005) 0.83
Lipoprotein (a): a Unique Independent Risk Factor for Coronary Artery Disease. Indian J Clin Biochem (2015) 0.79
Role of homocysteinylation of ACE in endothelial dysfunction of arteries. Am J Physiol Heart Circ Physiol (2014) 0.76
Study of genetic, metabolic and inflammatory risk factors in patients of acute ischemic stroke. Indian J Clin Biochem (2008) 0.75
Clinical Characteristics of Patients Less than Forty Years Old with Coronary Artery Disease in Taiwan: A Cross-Sectional Study. Acta Cardiol Sin (2017) 0.75
Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med (1991) 6.03
Quadratic elongation: a quantitative measure of distortion in coordination polyhedra. Science (1971) 5.76
Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med (1997) 5.73
AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation (2000) 4.80
Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med (1995) 4.68
Targeted deletion of 5'HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus. Genes Dev (1995) 4.11
Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA (1997) 3.87
Association between myeloperoxidase levels and risk of coronary artery disease. JAMA (2001) 3.74
Determination of therapeutic serum concentrations of oral and parenteral meperidine by liquid chromatography. Eur J Clin Pharmacol (1976) 3.22
Safety of long-term lamotrigine in epilepsy. Epilepsia (1997) 2.92
Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med (1996) 2.81
Prescription-event monitoring (PEM) in 1996-a method of non-interventional observational cohort pharmacovigilance. Pharmacoepidemiol Drug Saf (1997) 2.33
Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death. Ann Intern Med (1995) 2.33
Synthesis of the literature on the effectiveness of regional anesthesia for cataract surgery. Ophthalmology (2001) 2.30
Discriminant analysis of ribotype profiles of Escherichia coli for differentiating human and nonhuman sources of fecal pollution. Appl Environ Microbiol (1999) 2.25
Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation (2001) 2.17
Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin Chem (1994) 2.14
Vitamins C and E inhibit O2- production in the pig coronary artery. Circulation (1997) 2.14
Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol (1984) 1.99
Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am J Respir Crit Care Med (1994) 1.98
AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Stroke (2000) 1.90
Association of body fat distribution and cardiovascular risk factors in children and adolescents. Circulation (1999) 1.87
Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation (2001) 1.69
Normalization of hyperhomocysteinemia with L-thyroxine in hypothyroidism. Ann Intern Med (1999) 1.64
Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice. BMJ (2000) 1.62
Overweight, fat patterning, and cardiovascular disease risk factors in black and white girls: The National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr (1999) 1.60
Prescription-event monitoring of 10,401 patients treated with fluvoxamine. Br J Psychiatry (1994) 1.58
Hyperlipidemia and pancreatitis during pregnancy in two sisters with a mutation in the lipoprotein lipase gene. Ann Intern Med (1996) 1.56
Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring. BMJ (1988) 1.55
Serum cobalamin, homocysteine, and methylmalonic acid concentrations in a multiethnic elderly population: ethnic and sex differences in cobalamin and metabolite abnormalities. Am J Clin Nutr (1999) 1.55
Community-based heart health promotion: perceptions of facilitators and barriers. Can J Public Health (1999) 1.55
New vascular classification of port-wine stains: improving prediction of Sturge-Weber risk. Br J Dermatol (2014) 1.53
The biogenesis of ethylene in penicillium digitatum. Plant Physiol (1968) 1.53
An embryo-lethal mutant of Arabidopsis thaliana is a biotin auxotroph. Dev Biol (1989) 1.53
Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC Group. Eur Heart J (1999) 1.52
A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients. J Hum Hypertens (2006) 1.51
Lactic acid bacteria as vaccine delivery vehicles. Antonie Van Leeuwenhoek (1996) 1.51
A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies. Br J Clin Pharmacol (1996) 1.47
Natural history of isolated bundle branch block. Am J Cardiol (1996) 1.46
Exposure to Helicobacter pylori infection in early childhood and the risk of allergic disease and atopic sensitization: a longitudinal birth cohort study. Clin Exp Allergy (2014) 1.46
Experimental aspects of peripheral vascular occlusion of the intestine. Surg Gynecol Obstet (1965) 1.45
Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine. Infect Immun (1998) 1.42
Community hospitals: new wine in old bottles? Br J Gen Pract (1998) 1.42
Overweight, fat patterning, and cardiovascular disease risk factors in black and white boys. J Pediatr (1999) 1.41
Sodium and potassium fluxes and compartmentation in roots of atriplex and oat. Plant Physiol (1985) 1.39
Homocysteine and coronary atherosclerosis. J Am Coll Cardiol (1996) 1.39
Comparability of the death certificate and the 1986 National Mortality Followback Survey. Vital Health Stat 2 (1993) 1.38
A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies. Pharmacoepidemiol Drug Saf (1997) 1.38
The time interval between death and next-of-kin contact and its effects on response rates and data quality. Am J Epidemiol (1991) 1.38
A guideline misguided: a review of the 2006 KDOQI Guideline on surveillance/monitoring and prophylactic angioplasty of hemodialysis grafts. J Vasc Access (2008) 1.37
Abnormalities of the auditory evoked potentials in patients with multiple sclerosis. Brain (1977) 1.35
The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England. Br J Obstet Gynaecol (1998) 1.31
Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler Thromb Vasc Biol (1995) 1.31
Homocysteine and its disulfide derivatives: a suggested consensus terminology. Arterioscler Thromb Vasc Biol (2000) 1.30
Signs and symptoms of patients with brain tumors presenting to the emergency department. J Emerg Med (1993) 1.29
Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients. J Clin Invest (1986) 1.28
Sexual maturation and obesity in 9- and 10-year-old black and white girls: the National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr (1994) 1.26
The frequency of breech presentation by gestational age at birth: a large population-based study. Am J Obstet Gynecol (1992) 1.24
The association of LDL receptor activity, LDL cholesterol level, and clinical course in homozygous familial hypercholesterolemia. Metabolism (1985) 1.23
Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies. Br J Clin Pharmacol (1998) 1.23
Protein and lipid oxidation of banked human erythrocytes: role of glutathione. Free Radic Biol Med (1999) 1.21
Molecular typing of candida albicans isolated from oral lesions of HIV-infected individuals. AIDS (1992) 1.20
rab3A attachment to the synaptic vesicle membrane mediated by a conserved polyisoprenylated carboxy-terminal sequence. Neuron (1991) 1.20
Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation (1996) 1.19
Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia. Am J Cardiol (1998) 1.18
Molecular epidemiology of recurrent oral candidiasis in human immunodeficiency virus-positive patients: evidence for two patterns of recurrence. J Infect Dis (1993) 1.18
Studies of the sodium-calcium exchanger in bull-frog atrial myocytes. J Physiol (1988) 1.17
Two-dimensional electrophoresis of human plasma apolipoproteins. Clin Chem (1984) 1.17
Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency. J Clin Invest (1990) 1.16
Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. J Am Coll Cardiol (1993) 1.16
Sulfite hypersensitivity. A critical review. CRC Crit Rev Toxicol (1987) 1.16
Recovery of function in survivors of the acute respiratory distress syndrome. Am J Respir Crit Care Med (1994) 1.15
Albumin thiolate anion is an intermediate in the formation of albumin-S-S-homocysteine. J Biol Chem (2001) 1.15
Hyperhomocysteinemia and oxidative stress: time for a reality check? Arterioscler Thromb Vasc Biol (2000) 1.14
A time- and voltage-dependent K+ current in single cardiac cells from bullfrog atrium. J Gen Physiol (1986) 1.14
Identification and characterization of App: an immunogenic autotransporter protein of Neisseria meningitidis. Mol Microbiol (2001) 1.12
Auditory evoked responses in multiple sclerosis. Lancet (1975) 1.11
A data acquisition, display and plotting program for the IBM PC. Comput Methods Programs Biomed (1986) 1.11
Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome. Am Rev Respir Dis (1993) 1.11
Adverse effects associated with the use of donepezil in general practice in England. J Psychopharmacol (2000) 1.10
A prospective study in the Australian petroleum industry. II. Incidence of cancer. Br J Ind Med (1991) 1.10
Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England. Eur J Clin Pharmacol (2001) 1.10
Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease. Adv Enzyme Regul (1999) 1.10
Newer antidepressants: a comparison of tolerability in general practice. Br J Gen Pract (1999) 1.09
The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities. Eur J Haematol (1995) 1.09
Expression of transcobalamin II receptors by human leukemia K562 and HL-60 cells. Blood (1990) 1.08
The flexion-rotation test and active cervical mobility--a comparative measurement study in cervicogenic headache. Man Ther (2004) 1.08
Glutathione protects chemokine-scavenging and antioxidative defense functions in human RBCs. Am J Physiol Cell Physiol (2001) 1.08
Heterologous expression of an immunogenic pneumococcal type 3 capsular polysaccharide in Lactococcus lactis. Infect Immun (2000) 1.08
Male sex workers in three Australian cities: socio-demographic and sex work characteristics. J Homosex (2001) 1.08
Constraints on the cerebral basis for semantic processing from neuroimaging studies of Alzheimer's disease. J Neurol Neurosurg Psychiatry (1997) 1.07
Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway. Biochim Biophys Acta (2000) 1.07
Support needs of pregnant and parenting high school students. J Sch Nurs (1993) 1.07
The Strengths and Difficulties Questionnaire: a pilot study of a new computer version of the self-report scale. Eur Child Adolesc Psychiatry (2003) 1.05